RECKITT BENCKISER GROUP PLC
Company number 06270876 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Credit Assessment: RECKITT BENCKISER GROUP PLC
1. Credit Opinion: APPROVE
Reasoning: Reckitt Benckiser Group PLC is a FTSE 100 constituent and one of the world's leading consumer goods companies, home to powerhouse brands including Dettol, Lysol, Finish, Nurofen, Durex, and Gaviscon. The company operates in defensive consumer staples sectors (hygiene, health, nutrition) that demonstrate resilient demand characteristics through economic cycles. Filing compliance is exemplary with no overdue documents, and the governance structure is robust with an experienced, international board featuring clear executive leadership (CEO: Laxman Narasimhan; CFO: Jeffrey Carr) and strong non-executive representation. This entity represents minimal credit risk for standard commercial facilities.
2. Financial Strength
Share Capital: £73.65 million in issued share capital, consistent with a major PLC structure.
Balance Sheet Indicators: - Group accounts filed, indicating consolidated reporting including subsidiaries—standard for a complex multinational - The corporate structure (SIC 70100 - Activities of head offices) confirms this is the ultimate parent entity, meaning covenant monitoring should target group-level financials where substance resides - No indication of capital inadequacy or distress signals
Assessment: As a large-cap public company with access to capital markets, financial strength is substantial. The defensive nature of the product portfolio (essential health and hygiene products) provides natural revenue insulation against economic downturns. Brand equity across multiple categories creates significant intangible value not fully reflected in filed numbers.
3. Cash Flow Assessment
Liquidity Position: While detailed cash flow data is not available in this filing extract, the following structural factors support strong liquidity assessment:
- Revenue Diversity: Global operations across 60+ countries mitigate geographic concentration risk
- Brand Portfolio: Market-leading positions in multiple categories generate pricing power and reliable cash conversion
- Working Capital: Consumer staples businesses typically operate with favorable working capital dynamics—strong receivables collection from diversified retail customer base
- Capital Markets Access: PLC status provides equity and debt capital market access as a liquidity backstop
Potential Consideration: The company has historically carried significant leverage following acquisitions (notably the Mead Johnson acquisition in 2017). Debt service capability should be verified against current leverage ratios and interest coverage when full accounts are available.
4. Monitoring Points
| Metric | Rationale |
|---|---|
| Net Debt/EBITDA | Track deleveraging progress; historical acquisitions elevated leverage |
| Interest Coverage | Ensure earnings adequately service debt obligations |
| Organic Revenue Growth | Distinguish between acquisitive and organic growth trajectory |
| Gross Margin Trends | Input cost inflation (commodities, logistics) may compress margins |
| Free Cash Flow Conversion | Verify cash generation supports dividend policy AND debt reduction |
| Filing Timeliness | Currently exemplary—any deviation would be a red flag |
| Director Changes | Recent CEO transition (Narasimhan appointed 2019); monitor board stability |
| Litigation Provisions | Monitor for material product liability or regulatory actions |
Sector Context Note
The hygiene and health sector has experienced elevated demand post-pandemic, with some normalization expected. Reckitt's portfolio positioning in essential categories provides a floor under performance, though comparisons to peak demand periods may show headline declines. Medium-term growth drivers (emerging market penetration, health and wellness trends, e-commerce expansion) remain intact.